Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart vs Human Insulin in Pregnant Women with Type 1 Diabetes
NCT00365170Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2002
- Primary completion
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
Phase 4, randomised, open-label trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Relative risk of major maternal hypoglycaemia. Started Sep 2002; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00365170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365170.